MARKET

BIVIW

BIVIW

Biovie Inc
NASDAQ
0.2620
0.00
0.00%
Opening 09:30 02/10 EST
OPEN
--
PREV CLOSE
0.2620
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.5200
52 WEEK LOW
0.2000
MARKET CAP
--
P/E (TTM)
-0.0294
1D
5D
1M
3M
1Y
5Y
1D
OPTION THERAPEUTICS INC SAYS THINKEQUITY IS THE UNDERWRITER TO IPO
Reuters · 01/26 11:03
BioVie Inc. unveils new data on bezisterim's potential in Parkinson's and Alzheimer's therapies
Reuters · 01/10 18:53
BioVie Completes Enrollment for Phase 2 SUNRISE-PD Trial Testing Bezisterim in Early Parkinson’s Disease
Reuters · 01/08 13:02
BIOVIE COMPLETES ENROLLMENT IN PHASE 2 SUNRISE-PD TRIAL IN EARLY PARKINSON’S DISEASE
Reuters · 01/08 13:00
BIOVIE INC - TOPLINE RESULTS FROM SUNRISE-PD TRIAL EXPECTED IN 1H 2026
Reuters · 01/08 13:00
Halozyme Therapeutics Elects Jim Lang to Board of Directors
Reuters · 12/08/2025 21:05
BioVie Inc. Files Initial Statement of Beneficial Ownership for Director Kameel D. Farag
Reuters · 10/28/2025 15:20
BioVie Inc. Files Initial Beneficial Ownership Statement for Director Amy Suzon Chappell
Reuters · 10/27/2025 22:36
More

Webull offers Biovie Inc stock information, including NASDAQ: BIVIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIVIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIVIW stock methods without spending real money on the virtual paper trading platform.